Airway infection, such as atypical bacterium Mycoplasma pneumoniae (Mp), contributes to asthma pathobiology. One key unanswered question is: What are the lung immunologic and molecular mechanisms by which asthmatics are susceptible to bacterial infections? Specifically, does an established allergic airway milieu in asthmatics enhance host susceptibility to Mp infection? Our previous studies in mouse models and human primary airway epithelial cell cultures have demonstrated that: 1) Mp activates Toll-like receptor 2 (TLR2) signaling pathway in mouse lungs including airway epithelial cells and dendritic cells (DCs), and human primary bronchial epithelial cells;2) TLR2 activation is critical for host defense against Mp infection through induction of Th1 response and antimicrobial substances;3) Allergic inflammation and/or Th2 cytokines reduce TLR2 activation, leading to an impaired lung Mp clearance (or a persistent low level of Mp);4) TLR2 activation using Pam3CSK4 (a TLR2 ligand) or neutralizing IL-4 and IL-13 in allergic mice restore the impaired Mp clearance;and 5) In an established allergic milieu, Mp infection, particularly at a low dose, increases Th2 differentiation. Our preliminary studies led us to hypothesize that an established allergic airway milieu down-regulates innate immunity (i.e., TLR2 activation), predisposes the host to a persistent low level of Mp infection, and consequently leads to an increased allergic airway response. To test this central hypothesis, we have proposed three specific aims.
Aim 1 is to test the hypothesis that an established allergic airway milieu reduces TLR2 activation in Mp-infected mice, leading to a persistent low level of lung Mp. TLR2 activation (use of TLR2 ligand Pam3CSK4 or adoptive DC transfer) prior to the establishment of allergic inflammation will restore the impaired Mp clearance in allergic lungs by promoting the Th1 response.
Aim 2 is to test the hypothesis that upon Mp infection, Th2 cytokines (IL-4, IL-13) inhibit TLR2 activation of airway epithelial cells (less TLR2 and antimicrobial substances) and lung DCs (less TLR2 and Th1-driving cytokine [e.g., IL-12] production). IL-4 and IL-13 inhibit Mp-induced TLR2 activation through suppressing NF-?B activity via signal transducer and activator of transcription 6 (STAT6) signaling pathway.
Aim 3 is to test the hypothesis that in contrast to higher doses, lower doses of Mp in an allergic milieu enhance allergic responses. Lower doses of Mp fail to induce TLR2 activation in Th2 cytokine-exposed DCs, leading to a DC phenotype (e.g., increased Jagged1 expression) in favor of Th2 differentiation of naive CD4+ T cells. Our proposed studies will reveal novel molecular mechanisms involved in an increased susceptibility of asthmatics to bacterial infections, which will provide the basic information in the design of therapeutic strategies to attenuate airway infectious and allergic processes in asthma. Project Narrative: Our research findings will significantly advance our knowledge with regard to the mechanisms of an increased susceptibility of asthmatics to bacterial infections, thus helping the design of novel therapeutic strategies in attenuating airway infectious and allergic processes in asthma and perhaps other chronic pulmonary diseases.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Project (R01)
Project #
Application #
Study Section
Lung Cellular, Molecular, and Immunobiology Study Section (LCMI)
Program Officer
Taylor, Christopher E,
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
National Jewish Health
United States
Zip Code
Wu, Qun; van Dyk, Linda F; Jiang, Di et al. (2013) Interleukin-1 receptor-associated kinase M (IRAK-M) promotes human rhinovirus infection in lung epithelial cells via the autophagic pathway. Virology 446:199-206
Kratzer, Adelheid; Chu, Hong Wei; Salys, Jonas et al. (2013) Endothelial cell adhesion molecule CD146: implications for its role in the pathogenesis of COPD. J Pathol 230:388-98
Wu, Qun; Case, Stephanie R; Minor, Maisha N et al. (2013) A novel function of MUC18: amplification of lung inflammation during bacterial infection. Am J Pathol 182:819-27
Gally, Fabienne; Minor, Maisha N; Smith, Sean K et al. (2012) Heat shock factor 1 protects against lung mycoplasma pneumoniae infection in mice. J Innate Immun 4:59-68
Thaikoottathil, Jyoti V; Martin, Richard J; Di, Peter Y et al. (2012) SPLUNC1 deficiency enhances airway eosinophilic inflammation in mice. Am J Respir Cell Mol Biol 47:253-60
Wu, Qun; Jiang, Di; Smith, Sean et al. (2012) IL-13 dampens human airway epithelial innate immunity through induction of IL-1 receptor-associated kinase M. J Allergy Clin Immunol 129:825-833.e2
Thaikoottathil, Jyoti; Chu, Hong Wei (2011) MAPK/AP-1 activation mediates TLR2 agonist-induced SPLUNC1 expression in human lung epithelial cells. Mol Immunol 49:415-22
Simon, Glenn C; Martin, Richard J; Smith, Sean et al. (2011) Up-regulation of MUC18 in airway epithelial cells by IL-13: implications in bacterial adherence. Am J Respir Cell Mol Biol 44:606-13
Wu, Qun; Jiang, Di; Minor, Maisha N et al. (2011) In vivo function of airway epithelial TLR2 in host defense against bacterial infection. Am J Physiol Lung Cell Mol Physiol 300:L579-86
Chu, Hong Wei; Gally, Fabienne; Thaikoottathil, Jyoti et al. (2010) SPLUNC1 regulation in airway epithelial cells: role of Toll-like receptor 2 signaling. Respir Res 11:155

Showing the most recent 10 out of 12 publications